<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04685486</url>
  </required_header>
  <id_info>
    <org_study_id>1610017629</org_study_id>
    <nct_id>NCT04685486</nct_id>
  </id_info>
  <brief_title>Virtual Reality for Pain Management in Burn Patients</brief_title>
  <official_title>Virtual Reality for Pain Management in Burn Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized proof-of-concept study to assess the efficacy of Virtual Reality&#xD;
      (VR) vs standard of care in 50 adult patients in the New York Presbyterian Burn Unit. The&#xD;
      participants who are randomized to receive the virtual reality intervention will also receive&#xD;
      opioids, which is the standard of care and is known to be effective. Participants will be&#xD;
      randomly assigned to two groups. The first group will receive VR during their painful&#xD;
      procedure (e.g., wound dressing changes, physical therapy etc.) in addition to the standard&#xD;
      of care. The other group will receive standard of care (and no VR).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pain</measure>
    <time_frame>Peri-procedural: 30 minutes before to two hours after the painful event.</time_frame>
    <description>Initial determination of the clinical efficacy of VR in reducing the total pain (determined by the subjective standard 0-10 pain scale) where 0 = no pain and 10 = worst pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in narcotic dose</measure>
    <time_frame>Peri-procedural: 30 minutes before to two hours after the painful event.</time_frame>
    <description>Dose of narcotics needed peri-procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in narcotic dose</measure>
    <time_frame>Day 1 of hospitalization to last day of hospitalization (approximately 15 days)</time_frame>
    <description>Determine if the one-time VR-distraction intervention reduces dose of analgesics for the day after the painful events and the remained of the post-procedure hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in anxiolytics dose</measure>
    <time_frame>Day 1 of hospitalization to last day of hospitalization (approximately 15 days)</time_frame>
    <description>Determine if the one-time VR-distraction intervention reduces anxiolytic dose after painful event</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Anxiety Symptoms</measure>
    <time_frame>Peri-procedural: 30 minutes before to two hours after the painful event.</time_frame>
    <description>Determined by visual analog scales (0-100) where 0 = no anxiety and 100 = worst possible anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Depressive Symptoms</measure>
    <time_frame>Peri-procedural: 30 minutes before to two hours after the painful event.</time_frame>
    <description>Determined by visual analog scales (0-100) where 0 = no depression and 100 = worst possible depression.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Virtual Reality</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Virtual reality-enhanced distraction using a portable head mounted display during panful events (such as wound dressing changes or physical therapy sessions) in addition to standard of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as Usual</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care during painful event (such as wound dressing changes or physical therapy sessions).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Virtual Reality</intervention_name>
    <description>Immersive and interactive game played through a portable head-mounted display as a distraction mechanism</description>
    <arm_group_label>Virtual Reality</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  8 years and older&#xD;
&#xD;
          -  Patients with a burn injury and is in the Burn Unit at New York Presbyterian&#xD;
&#xD;
          -  Awake, alert, ambulatory&#xD;
&#xD;
          -  The burn comprises less than 15% total body surface area (TBSA)&#xD;
&#xD;
          -  The patient does not require conscious sedation such as ketamine for staple removal or&#xD;
             wound dressing changes&#xD;
&#xD;
          -  The patient is able to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of a cognitive disorder, psychotic disorder or bipolar I as determined by&#xD;
             self-report from previous diagnosis&#xD;
&#xD;
          -  Current opioid abuse&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>JoAnn Difede, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Medical College of Cornell University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mariel Emrich, BS</last_name>
    <phone>212-821-0783</phone>
    <email>mae2050@med.cornell.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Weill Cornell Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariel Emrich, BS</last_name>
      <phone>212-821-0783</phone>
      <email>mae2050@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>JoAnn Difede, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 22, 2020</study_first_submitted>
  <study_first_submitted_qc>December 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2020</study_first_posted>
  <last_update_submitted>December 22, 2020</last_update_submitted>
  <last_update_submitted_qc>December 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Virtual Reality</keyword>
  <keyword>Pain Management</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Depression</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

